PKD2L2
gene geneOn this page
Also known as TRPP5
Summary
PKD2L2 (polycystin 2 like 2, transient receptor potential cation channel, HGNC:9012) is a protein-coding gene on chromosome 5q31.2, encoding Polycystin-2-like protein 2 (Q9NZM6). Exhibits a lower single conductance but no spontaneous channel activity.
Predicted to enable calcium channel activity. Predicted to be involved in detection of mechanical stimulus. Predicted to be active in membrane.
Source: NCBI Gene 27039 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 89 total
- MANE Select transcript:
NM_001300921
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:9012 |
| Approved symbol | PKD2L2 |
| Name | polycystin 2 like 2, transient receptor potential cation channel |
| Location | 5q31.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TRPP5 |
| Ensembl gene | ENSG00000078795 |
| Ensembl biotype | protein_coding |
| OMIM | 604669 |
| Entrez | 27039 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 6 protein_coding, 1 nonsense_mediated_decay
ENST00000290431, ENST00000414094, ENST00000502810, ENST00000503015, ENST00000508638, ENST00000508883, ENST00000511176
RefSeq mRNA: 4 — MANE Select: NM_001300921
NM_001258448, NM_001258449, NM_001300921, NM_014386
CCDS: CCDS43367, CCDS58971, CCDS58972, CCDS78062
Canonical transcript exons
ENST00000508883 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000453155 | 137906206 | 137906434 |
| ENSE00000453156 | 137907742 | 137907912 |
| ENSE00000764038 | 137892480 | 137892613 |
| ENSE00000764043 | 137908765 | 137908946 |
| ENSE00000764044 | 137921636 | 137921756 |
| ENSE00000764046 | 137925040 | 137925104 |
| ENSE00000764047 | 137925875 | 137925929 |
| ENSE00000817407 | 137935797 | 137935909 |
| ENSE00001196083 | 137923420 | 137923521 |
| ENSE00002048655 | 137936320 | 137936427 |
| ENSE00002074575 | 137889457 | 137889522 |
| ENSE00002083568 | 137942384 | 137942747 |
| ENSE00003627511 | 137894353 | 137894609 |
| ENSE00003635142 | 137899516 | 137899737 |
| ENSE00003687014 | 137890481 | 137890582 |
Expression profiles
Bgee: expression breadth ubiquitous, 164 present calls, max score 86.23.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2095 / max 33.8314, expressed in 79 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 58741 | 0.1364 | 44 |
| 58742 | 0.0731 | 15 |
Top tissues by expression
275 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tendon of biceps brachii | UBERON:0008188 | 86.23 | silver quality |
| buccal mucosa cell | CL:0002336 | 85.30 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.46 | gold quality |
| left testis | UBERON:0004533 | 76.65 | gold quality |
| right testis | UBERON:0004534 | 75.70 | gold quality |
| testis | UBERON:0000473 | 75.15 | gold quality |
| tendon | UBERON:0000043 | 73.33 | gold quality |
| sperm | CL:0000019 | 72.80 | gold quality |
| medial globus pallidus | UBERON:0002477 | 72.02 | gold quality |
| male germ cell | CL:0000015 | 71.69 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 70.15 | gold quality |
| globus pallidus | UBERON:0001875 | 66.32 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 66.13 | gold quality |
| calcaneal tendon | UBERON:0003701 | 66.06 | gold quality |
| muscle of leg | UBERON:0001383 | 64.02 | gold quality |
| gastrocnemius | UBERON:0001388 | 63.70 | gold quality |
| adrenal tissue | UBERON:0018303 | 60.95 | gold quality |
| monocyte | CL:0000576 | 60.78 | gold quality |
| mononuclear cell | CL:0000842 | 60.59 | gold quality |
| bone marrow cell | CL:0002092 | 60.42 | gold quality |
| muscle organ | UBERON:0001630 | 60.29 | gold quality |
| leukocyte | CL:0000738 | 59.31 | gold quality |
| heart left ventricle | UBERON:0002084 | 57.84 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 57.81 | gold quality |
| colonic epithelium | UBERON:0000397 | 57.76 | silver quality |
| left adrenal gland | UBERON:0001234 | 57.64 | gold quality |
| cardiac ventricle | UBERON:0002082 | 57.26 | gold quality |
| right adrenal gland | UBERON:0001233 | 57.08 | gold quality |
| adrenal gland | UBERON:0002369 | 57.05 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 56.73 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7316 | no | 304.01 |
| E-ANND-3 | no | 5.05 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
27 targeting PKD2L2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-636 | 99.80 | 69.58 | 1500 |
| HSA-MIR-323A-3P | 99.79 | 70.30 | 1739 |
| HSA-MIR-1825 | 99.72 | 68.11 | 1089 |
| HSA-MIR-802 | 99.61 | 67.70 | 1254 |
| HSA-MIR-549A-3P | 99.54 | 68.17 | 825 |
| HSA-MIR-5584-3P | 99.23 | 68.79 | 1351 |
| HSA-MIR-194-5P | 99.01 | 69.65 | 1465 |
| HSA-MIR-502-5P | 98.77 | 66.51 | 906 |
| HSA-MIR-4635 | 98.74 | 67.63 | 1339 |
| HSA-MIR-583 | 98.71 | 67.44 | 1791 |
| HSA-MIR-7158-3P | 98.46 | 66.45 | 728 |
| HSA-MIR-654-3P | 98.38 | 67.61 | 905 |
| HSA-MIR-10395-3P | 98.10 | 66.70 | 1726 |
| HSA-MIR-12116 | 97.94 | 68.91 | 595 |
| HSA-MIR-203B-3P | 97.82 | 66.27 | 979 |
| HSA-MIR-127-5P | 97.78 | 67.64 | 869 |
| HSA-MIR-4670-3P | 97.37 | 68.35 | 1378 |
| HSA-MIR-10397-5P | 97.31 | 69.06 | 710 |
| HSA-MIR-517-5P | 97.13 | 68.43 | 781 |
| HSA-MIR-4689 | 96.97 | 65.79 | 1209 |
| HSA-MIR-6858-5P | 96.05 | 64.59 | 1020 |
Cross-species orthologs
8 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | pkd1a | ENSDARG00000030417 |
| danio_rerio | pkd1l2b | ENSDARG00000088121 |
| danio_rerio | pkd1l2b | ENSDARG00000101214 |
| danio_rerio | pkd1l2a | ENSDARG00000105344 |
| mus_musculus | Pkd2l2 | ENSMUSG00000014503 |
| rattus_norvegicus | Pkd2l2 | ENSRNOG00000025489 |
| drosophila_melanogaster | Pkd2 | FBGN0041195 |
| caenorhabditis_elegans | WBGENE00004035 |
Paralogs (10): PKD1 (ENSG00000008710), PKD2L1 (ENSG00000107593), PKD2 (ENSG00000118762), PKDREJ (ENSG00000130943), PKD1L1 (ENSG00000158683), PKD1L2 (ENSG00000166473), LOXHD1 (ENSG00000167210), DENND5B (ENSG00000170456), DENND5A (ENSG00000184014), PKD1L3 (ENSG00000277481)
Protein
Protein identifiers
Polycystin-2-like protein 2 — Q9NZM6 (reviewed: Q9NZM6)
Alternative names: Polycystic kidney disease 2-like 2 protein, Polycystin-L2
All UniProt accessions (3): Q9NZM6, D6RBX8, D6RF71
UniProt curated annotations — full annotation on UniProt →
Function. Exhibits a lower single conductance but no spontaneous channel activity. May function as a regulator of calcium channels or a channel component involving Ca2(+) homeostasis.
Subunit / interactions. Interacts with TRPC1 and TRPC5.
Subcellular location. Membrane.
Tissue specificity. Expressed only in testis. Expressed also in brain and kidney. Expressed only in transformed lymphoblasts.
Similarity. Belongs to the polycystin family.
Isoforms (7)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NZM6-1 | 1 | yes |
| Q9NZM6-2 | 2, PKD2L2b | |
| Q9NZM6-3 | 3, PKD2L2a | |
| Q9NZM6-4 | 4, PKD2L2c | |
| Q9NZM6-5 | 5 | |
| Q9NZM6-6 | 6 | |
| Q9NZM6-7 | 7 |
RefSeq proteins (4): NP_001245377, NP_001245378, NP_001287850, NP_055201 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003915 | PKD_2 | Family |
| IPR013122 | PKD1_2_channel | Domain |
| IPR046791 | Polycystin_dom | Domain |
| IPR051223 | Polycystin | Family |
Pfam: PF08016, PF20519
UniProt features (29 total): splice variant 9, topological domain 7, transmembrane region 6, glycosylation site 2, sequence variant 2, chain 1, coiled-coil region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NZM6-F1 | 81.39 | 0.47 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 115, 138
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 89 (showing top):
GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_DETECTION_OF_MECHANICAL_STIMULUS, GGGCATT_MIR365, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, AACTTT_UNKNOWN, GOBP_DETECTION_OF_ABIOTIC_STIMULUS, GOBP_DETECTION_OF_STIMULUS, POU3F2_02, GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOBP_TRANSMEMBRANE_TRANSPORT, GOBP_RESPONSE_TO_MECHANICAL_STIMULUS, chr5q31, GOMF_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY
GO Biological Process (4): detection of mechanical stimulus (GO:0050982), monoatomic ion transport (GO:0006811), monoatomic ion transmembrane transport (GO:0034220), calcium ion transmembrane transport (GO:0070588)
GO Molecular Function (2): calcium channel activity (GO:0005262), calcium ion binding (GO:0005509)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| detection of external stimulus | 1 |
| detection of abiotic stimulus | 1 |
| response to mechanical stimulus | 1 |
| transport | 1 |
| monoatomic ion transport | 1 |
| transmembrane transport | 1 |
| calcium ion transport | 1 |
| monoatomic cation transmembrane transport | 1 |
| monoatomic cation channel activity | 1 |
| calcium ion transmembrane transporter activity | 1 |
| metal ion binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
696 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PKD2L2 | MCOLN1 | Q9GZU1 | 619 |
| PKD2L2 | TRPM2 | O94759 | 612 |
| PKD2L2 | TRPA1 | O75762 | 603 |
| PKD2L2 | PKD1L3 | Q7Z443 | 590 |
| PKD2L2 | TRPC1 | P48995 | 588 |
| PKD2L2 | PKD1L1 | Q8TDX9 | 587 |
| PKD2L2 | FAM13B | Q9NYF5 | 541 |
| PKD2L2 | TRPM5 | Q9NZQ8 | 537 |
| PKD2L2 | TRPM4 | Q8TD43 | 537 |
| PKD2L2 | TRPM7 | Q96QT4 | 537 |
| PKD2L2 | TRPM3 | Q9HCF6 | 530 |
| PKD2L2 | TRPV5 | Q9NQA5 | 519 |
| PKD2L2 | TRPV1 | Q8NER1 | 519 |
| PKD2L2 | TRPM8 | Q7Z2W7 | 513 |
| PKD2L2 | TRPV2 | Q9Y5S1 | 513 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PKD2L2 | PKD2 | psi-mi:“MI:0914”(association) | 0.530 |
| PKD2L2 | SERPINB3 | psi-mi:“MI:0914”(association) | 0.350 |
| P | psi-mi:“MI:0914”(association) | 0.350 | |
| PKD2L2 | SEMG1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (15): PKD2 (Affinity Capture-MS), SERPINB4 (Affinity Capture-MS), CCPG1 (Affinity Capture-MS), SERPINB3 (Affinity Capture-MS), CCPG1 (Affinity Capture-MS), GRAMD1A (Affinity Capture-MS), ITPR3 (Affinity Capture-MS), TRPM4 (Affinity Capture-MS), TRPM7 (Affinity Capture-MS), DNAJB9 (Affinity Capture-MS), PKD2 (Affinity Capture-MS), SEMG1 (Affinity Capture-MS), PKD2L2 (Cross-Linking-MS (XL-MS)), PKD2L2 (Protein-peptide), PKD2L2 (Affinity Capture-RNA)
ESM2 similar proteins: A1A5B4, A2A259, A2AIR5, E9PTA2, F6RG56, H2Q5A1, O35245, O62826, O70212, O94759, P02715, P04758, P09690, P11230, P13536, P23979, P25109, P35563, P37088, Q04671, Q13507, Q13563, Q4GZT3, Q60HE8, Q6IVV8, Q7Z403, Q86V40, Q8BWC0, Q8MIQ9, Q8R4F0, Q8TCT7, Q8TCU5, Q8TDD5, Q91YD4, Q96BD0, Q99J21, Q9EQJ0, Q9GZU1, Q9HA82, Q9JJH7
Diamond homologs: A2A259, H2LRU7, O35245, Q13563, Q4GZT3, Q6IVV8, Q9HCX4, Q9JLG4, Q9NZM6, Q9P0L9, Q9U1S7, Q9WVC5, Q7TN88, Q9JMI9, Q9QZC1, Q13507
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
89 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 79 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2574 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:137890540:G:GT | donor_gain | 1.0000 |
| 5:137892543:T:TA | acceptor_gain | 1.0000 |
| 5:137892544:G:A | acceptor_gain | 1.0000 |
| 5:137894348:T:TA | acceptor_gain | 1.0000 |
| 5:137894349:G:A | acceptor_gain | 1.0000 |
| 5:137894608:GA:G | donor_gain | 1.0000 |
| 5:137894610:G:GG | donor_gain | 1.0000 |
| 5:137899672:G:T | donor_gain | 1.0000 |
| 5:137925028:A:G | acceptor_gain | 1.0000 |
| 5:137925927:AATG:A | donor_loss | 1.0000 |
| 5:137925928:AT:A | donor_gain | 1.0000 |
| 5:137925929:TGT:T | donor_loss | 1.0000 |
| 5:137925930:G:GC | donor_loss | 1.0000 |
| 5:137925930:G:GG | donor_gain | 1.0000 |
| 5:137925931:T:G | donor_loss | 1.0000 |
| 5:137935910:G:GG | donor_gain | 1.0000 |
| 5:137941922:A:AC | donor_gain | 1.0000 |
| 5:137941923:A:C | donor_gain | 1.0000 |
| 5:137941939:CAAA:C | donor_loss | 1.0000 |
| 5:137941940:AAACC:A | donor_loss | 1.0000 |
| 5:137941941:AACCT:A | donor_loss | 1.0000 |
| 5:137941942:ACC:A | donor_loss | 1.0000 |
| 5:137941946:T:TA | donor_gain | 1.0000 |
| 5:137942041:CAGGC:C | acceptor_gain | 1.0000 |
| 5:137942042:AGGCC:A | acceptor_loss | 1.0000 |
| 5:137942044:GCC:G | acceptor_loss | 1.0000 |
| 5:137942045:CCT:C | acceptor_loss | 1.0000 |
| 5:137942046:C:CC | acceptor_gain | 1.0000 |
| 5:137942046:CTAGA:C | acceptor_loss | 1.0000 |
| 5:137942047:T:C | acceptor_loss | 1.0000 |
AlphaMissense
4145 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:137894480:G:C | R132P | 0.996 |
| 5:137899722:T:C | L244P | 0.990 |
| 5:137899658:T:A | W223R | 0.989 |
| 5:137899658:T:C | W223R | 0.989 |
| 5:137908846:T:C | F410L | 0.988 |
| 5:137908848:T:A | F410L | 0.988 |
| 5:137908848:T:G | F410L | 0.988 |
| 5:137907904:T:A | W380R | 0.987 |
| 5:137907904:T:C | W380R | 0.987 |
| 5:137921650:G:C | R448P | 0.984 |
| 5:137894486:T:C | L134P | 0.983 |
| 5:137899708:T:A | N239K | 0.982 |
| 5:137899708:T:G | N239K | 0.982 |
| 5:137907884:C:A | A373D | 0.982 |
| 5:137923433:C:A | A488E | 0.982 |
| 5:137894477:T:A | V131D | 0.980 |
| 5:137908891:G:A | G425R | 0.979 |
| 5:137908891:G:C | G425R | 0.979 |
| 5:137908924:T:C | F436L | 0.979 |
| 5:137908926:T:A | F436L | 0.979 |
| 5:137908926:T:G | F436L | 0.979 |
| 5:137908825:T:C | C403R | 0.978 |
| 5:137908883:C:A | A422D | 0.978 |
| 5:137908892:G:A | G425E | 0.978 |
| 5:137894483:A:C | Q133P | 0.975 |
| 5:137908882:G:C | A422P | 0.975 |
| 5:137908805:T:C | L396P | 0.974 |
| 5:137894454:T:A | N123K | 0.973 |
| 5:137894454:T:G | N123K | 0.973 |
| 5:137908903:T:C | F429L | 0.973 |
dbSNP variants (sampled 300 via entrez): RS1000047072 (5:137924694 T>G), RS1000118186 (5:137914518 T>G), RS1000374652 (5:137928237 T>C), RS1000427200 (5:137928572 C>T), RS1000546275 (5:137905363 C>G), RS1000659920 (5:137942325 G>A), RS1000693958 (5:137917948 T>C), RS1000703164 (5:137921658 C>A), RS1000720070 (5:137942648 C>A), RS1000756336 (5:137919828 G>A,T), RS1000817927 (5:137892795 C>T), RS1000830598 (5:137900438 A>C), RS1000887764 (5:137898549 T>C,G), RS1000940129 (5:137935836 A>C,G), RS1001082221 (5:137907514 A>G)
Disease associations
OMIM: gene MIM:604669 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004297_4 | Atrial fibrillation | 1.000000e-08 |
| GCST004521_66 | Autism spectrum disorder or schizophrenia | 1.000000e-08 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: vgic — Transient Receptor Potential channels (TRP)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects acetylation, affects methylation, decreases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| monomethylarsonous acid | affects acetylation, affects methylation | 1 |
| perfluorohexanesulfonic acid | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Lead | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_YA76 | IDG-HEK293T-PKD2L2-V5-OE | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.